All Stories

  1. Dolutegravir plus rilpivirine as dual regimen in virologically suppressed HIV-1 infected patients in a clinical setting

    Article • HIV Research & Clinical Practice, April 2019, Taylor & Francis

    Dr Jose L Casado, Marta Monsalvo Hernando, Pilar Vizcarra